Building better lipid nanoparticles for drug delivery: Structural biologists and pharmaceutical scientists have teamed up to improve the drug delivery system made famous by the Covid vaccines

Pharmaceutical scientists and biologists are teaming up to make the next generation of lipid nanoparticles (LNPs) for drug delivery. Combining structural biology with cutting edge pharmaceutical science, the team is designing LNPs that can precisely deliver vaccines and therapeutics to target tissues while improving the product's shelf life and duration of action.